Innate and adaptive immunity during SARS-CoV-2 infection: biomolecular cellular markers and mechanisms

B Brown, V Ojha, I Fricke, SA Al-Sheboul, C Imarogbe… - Vaccines, 2023 - mdpi.com
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-
stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Importance, applications and features of assays measuring SARS-CoV-2 neutralizing antibodies

P Gattinger, A Ohradanova-Repic… - International Journal of …, 2023 - mdpi.com
More than three years ago, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) caused the unforeseen COVID-19 pandemic with millions of deaths. In the …

An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2

P Immordino, V Pisciotta, E Amodio, C Bonura… - Vaccines, 2023 - mdpi.com
Although the anti-COVID-19 vaccination has proved to be an effective preventive
tool,“breakthrough infections” have been documented in patients with complete primary …

Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19

KH Hsieh, CH Chao, YL Cheng, YC Lai… - Journal of biomedical …, 2024 - Springer
Background High levels of neutrophil extracellular trap (NET) formation or NETosis and
autoantibodies are related to poor prognosis and disease severity of COVID-19 patients …

Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis

Y Pang, H Lu, D Cao, X Zhu, Q Long, F Tian, X Long… - BMC Public Health, 2024 - Springer
Objective A notable research gap exists in the systematic review and meta-analysis
concerning the efficacy, immunogenicity, and safety of the respiratory syncytial virus (RSV) …

Immunopathogenesis of Orthopoxviridae: insights into immunology from smallpox to monkeypox (mpox)

B Brown, C Imarogbe, I Fricke, A Gonzalez, P Mensah - 2023 - preprints.org
Since 2019, notable global viral outbreaks have occurred necessitating further research and
healthcare system investigations. Following the COVID—19 pandemic, an unexpected …

Ethical implications of developing RNA-based therapies for cardiovascular disorders

M Hostiuc, A Scafa, B Iancu, D Iancu… - … in Bioengineering and …, 2024 - frontiersin.org
The awareness concerning RNA-based therapies was boosted significantly after the
successful development of COVID-19 vaccines. However, they can potentially lead to …

Live attenuated COVID-19 vaccines: approaches to development and prospects for clinical use

ER Korchevaya, AV Gracheva, IN Dyakov… - Journal of …, 2023 - microbiol.crie.ru
Although WHO declared an end to the pandemic, COVID-19 remains a significant public
health concern worldwide. Modern vaccines often induce either only humoral or only cellular …

Measles: 1963-2023, Immunology of a Morbillivirus

B Brown - 2023 - europepmc.org
Measles is a virus, abbreviated to MeV, that has long been known to be causal in infant
disease and affect infant mortality, remaining a public health issue of priority. The causal …

[PDF][PDF] Understanding measles virus at 70 years: From cellular mechanisms to immunisation 1954-2024

B Brown, I Fricke, C Imarogbe, J Sheringham… - researchgate.net
Measles virus (Morbillivirus abbreviated as MV, but more recently MeV) is the causal agent
of Measles disease, thought to have existed at least 4000 years ago, affecting predominantly …